Evidence map›Paper›PMID 11032816›Full record

ArticleThe EMBO journal2000

Human DNA ligase I efficiently seals nicks in nucleosomes.

D R Chafin, J M Vitolo, L A Henricksen, R A Bambara, J J Hayes

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Generation of Recombinant Nucleosomes Containing Site-Specific DNA Damage.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

D R ChafinDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA.
J M Vitolo
L A Henricksen
R A Bambara
J J Hayes
University of Rochester Medical Center · US

Funding

Histone Tall Interactions and Functions in ChromatinR01GM052426 · NIGMS · UNIVERSITY OF ROCHESTER · PI HAYES, JEFFREY J · 1995 to 2021
$6.2M
TRAINING PROGRAM IN ORAL SCIENCET32DE007202 · NIDCR · UNIVERSITY OF ROCHESTER · PI QUIVEY, ROBERT G · 1990 to 2010
$5.5M
NIDCR NIH HHS T32 DE007202NIDCR NIH HHS T32 DE07202NIGMS NIH HHS GM52426NIGMS NIH HHS R01 GM052426
6 · The paper itself

Abstract

The access to DNA within nucleosomes is greatly restricted for most enzymes and trans-acting factors that bind DNA. We report here that human DNA ligase I, which carries out the final step of Okazaki fragment processing and of many DNA repair pathways, can access DNA that is wrapped about the surface of a nucleosome in vitro and carry out its enzymatic function with high efficiency. In addition, we find that ligase activity is not affected by the binding of linker histone (H1) but is greatly influenced by the disposition of the core histone tail domains. These results suggest that the window of opportunity for human DNA ligase I may extend well beyond the first stages of chromatin reassembly after DNA replication or repair.

Indexed as

AnimalsDeoxyribonucleases, Type II Site-SpecificDNADNA FootprintingDNA Ligase ATPDNA LigasesDNA RepairHistonesHumansHydroxyl RadicalMolecular ConformationMutationNucleosomesProtein BiosynthesisXenopusDeoxyribonucleases, Type II Site-SpecificDNADNA Ligase ATPDNA Ligasesendodeoxyribonuclease SacIHistonesHydroxyl RadicalLIG1 protein, humanNucleosomes

Identifiers

PMID11032816
PMCPMC314012
OpenAlexW2011523054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.